Global Thalidomide Market Insights, Forecast to 2025


Report ID : RNR-224371 Category : Pharma Healthcare Published Date : 2018
Publisher : QYResearch Pages : 92 Format : PDF
This report studies the global market size of Thalidomide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Thalidomide in these regions.

This research report categorizes the global Thalidomide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Thalidomide market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Thalidomide market based on company, product type, application and key regions.

The various contributors involved in the value chain of Thalidomide include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Thalidomide include

- Celgene

Market Size Split by Type

- Purity:98%

- Others

Market Size Split by Application

- Leprosy

- Arthropathy

Market size split by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Thalidomide market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

- To understand the structure of Thalidomide market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Thalidomide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Thalidomide with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Thalidomide submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Thalidomide are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Thalidomide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Global Thalidomide Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
1.1 Thalidomide Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Thalidomide Market Size Growth Rate by Type
1.4.2 Purity:98%
1.4.3 Others
1.5 Market by Application
1.5.1 Global Thalidomide Market Size Growth Rate by Application
1.5.2 Leprosy
1.5.3 Arthropathy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Thalidomide Market Size
2.1.1 Global Thalidomide Revenue 2016-2025
2.1.2 Global Thalidomide Sales 2016-2025
2.2 Thalidomide Growth Rate by Regions
2.2.1 Global Thalidomide Sales by Regions
2.2.2 Global Thalidomide Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Thalidomide Sales by Manufacturers
3.1.1 Thalidomide Sales by Manufacturers
3.1.2 Thalidomide Sales Market Share by Manufacturers
3.1.3 Global Thalidomide Market Concentration Ratio (CR5 and HHI)
3.2 Thalidomide Revenue by Manufacturers
3.2.1 Thalidomide Revenue by Manufacturers (2016-2018)
3.2.2 Thalidomide Revenue Share by Manufacturers (2016-2018)
3.3 Thalidomide Price by Manufacturers
3.4 Thalidomide Manufacturing Base Distribution, Product Types
3.4.1 Thalidomide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Thalidomide Product Category
3.4.3 Date of International Manufacturers Enter into Thalidomide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Thalidomide Sales by Type
4.2 Global Thalidomide Revenue by Type
4.3 Thalidomide Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Thalidomide Breakdown Data by Application
6 North America
6.1 North America Thalidomide by Countries
6.1.1 North America Thalidomide Sales by Countries
6.1.2 North America Thalidomide Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Thalidomide by Type
6.3 North America Thalidomide by Application
6.4 North America Thalidomide by Company
7 Europe
7.1 Europe Thalidomide by Countries
7.1.1 Europe Thalidomide Sales by Countries
7.1.2 Europe Thalidomide Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Thalidomide by Type
7.3 Europe Thalidomide by Application
7.4 Europe Thalidomide by Company
8 Asia Pacific
8.1 Asia Pacific Thalidomide by Countries
8.1.1 Asia Pacific Thalidomide Sales by Countries
8.1.2 Asia Pacific Thalidomide Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Thalidomide by Type
8.3 Asia Pacific Thalidomide by Application
8.4 Asia Pacific Thalidomide by Company
9 Central & South America
9.1 Central & South America Thalidomide by Countries
9.1.1 Central & South America Thalidomide Sales by Countries
9.1.2 Central & South America Thalidomide Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Thalidomide by Type
9.3 Central & South America Thalidomide by Application
9.4 Central & South America Thalidomide by Company
10 Middle East and Africa
10.1 Middle East and Africa Thalidomide by Countries
10.1.1 Middle East and Africa Thalidomide Sales by Countries
10.1.2 Middle East and Africa Thalidomide Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Thalidomide by Type
10.3 Middle East and Africa Thalidomide by Application
10.4 Middle East and Africa Thalidomide by Company
11 Company Profiles
11.1 Celgene
11.1.1 Celgene Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Thalidomide
11.1.4 Thalidomide Product Description
11.1.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Thalidomide Raw Material
13.1.2 Thalidomide Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Thalidomide
Figure Global Thalidomide Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Thalidomide Production Market Share by Types (Product Category) in 2017
Figure Purity:98% Product Picture
Table Major Manufacturers of Purity:98%
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Thalidomide Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Leprosy
Figure Arthropathy
Figure Thalidomide Report Years Considered
Figure Global Thalidomide Market Size 2016-2025 (Million US$)
Figure Global Thalidomide Sales 2016-2025 (K MT)
Table Global Thalidomide Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Thalidomide Sales by Regions 2016-2025 (K MT)
Table Global Thalidomide Sales Market Share by Regions 2016-2025
Figure Global Thalidomide Sales Market Share by Regions 2016-2025
Figure 2017 Global Thalidomide Sales Market Share by Regions
Table Global Thalidomide Revenue by Regions 2016-2025 (Million US$)
Table Global Thalidomide Revenue Market Share by Regions 2016-2025
Figure Global Thalidomide Revenue Market Share by Regions 2016-2025
Figure 2017 Global Thalidomide Revenue Market Share by Regions
Table Global Thalidomide Sales by Manufacturers (2016-2018) (K MT)
Table Global Thalidomide Sales Share by Manufacturers (2016-2018)
Figure Global Thalidomide Sales Share by Manufacturers in 2017
Table Thalidomide Revenue by Manufacturers (2016-2018) (Million US$)
Table Thalidomide Revenue Share by Manufacturers (2016-2018)
Figure Thalidomide Value Share by Manufacturers in 2017
Table Global Thalidomide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Thalidomide Price (2016-2018) (USD/MT)
Table Thalidomide Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Thalidomide Product Category
Table Date of International Manufacturers Enter into Thalidomide Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Thalidomide Sales by Type (2016-2025) (K MT)
Table Global Thalidomide Sales Share by Type (2016-2025)
Figure Global Thalidomide Sales Market Share by Type (2016-2025)
Figure Global Thalidomide Sales Market Share by Type in 2017
Table Global Thalidomide Revenue by Type (2016-2025) (Million US$)
Table Global Thalidomide Revenue Share by Type (2016-2025)
Figure Global Thalidomide Revenue Market Share by Type (2016-2025)
Figure Global Thalidomide Revenue Market Share by Type in 2017
Table Thalidomide Price by Type 2013-2018 (USD/MT)
Table Global Thalidomide Sales by Application (2016-2025) (K MT)
Table Global Thalidomide Sales Share by Application (2016-2025)
Figure Global Sales Thalidomide Market Share by Application (2016-2025)
Figure Global Sales Thalidomide Market Share by Application (2016-2025)
Figure North America Thalidomide Sales Growth Rate 2016-2025 (K MT)
Figure North America Thalidomide Revenue Growth Rate 2016-2025 (Million US$)
Table North America Thalidomide Sales by Countries (2016-2025) (K MT)
Table North America Thalidomide Sales Market Share by Countries (2016-2025)
Figure 2017 North America Thalidomide Sales Market Share by Countries
Table North America Thalidomide Revenue by Countries (2016-2025) (Million US$)
Table North America Thalidomide Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Thalidomide Revenue Market Share by Countries
Figure United States Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure United States Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Canada Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Table North America Thalidomide Sales by Type (2016-2025) (K MT)
Table North America Thalidomide Sales Market Share by Type (2016-2025)
Figure 2017 North America Thalidomide Market Share by Type
Table North America Thalidomide Sales by Application (2016-2025) (K MT)
Table North America Thalidomide Sales Market Share by Application (2016-2025)
Figure 2017 North America Thalidomide Market Share by Application
Table North America Thalidomide Sales by Company (2016-2018) (K MT)
Table North America Thalidomide Sales Market Share by Company (2016-2018)
Figure North America Thalidomide Sales Market Share by Company in 2017
Figure Europe Thalidomide Sales Growth Rate 2016-2025 (K MT)
Figure Europe Thalidomide Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Thalidomide Sales by Countries (2016-2025) (K MT)
Table Europe Thalidomide Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Thalidomide Sales Market Share by Countries
Table Europe Thalidomide Revenue by Countries (2016-2025) (Million US$)
Table Europe Thalidomide Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Thalidomide Revenue Market Share by Countries
Figure Germany Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Germany Thalidomide Revenue Growth Rate (2016-2025) (K MT)
Figure France Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure France Thalidomide Revenue Growth Rate (2016-2025) (K MT)
Figure UK Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure UK Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Italy Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Russia Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Thalidomide Sales by Type (2016-2025) (K MT)
Table Europe Thalidomide Sales Market Share by Type (2016-2025)
Figure 2017 Europe Thalidomide Market Share by Type
Table Europe Thalidomide Sales by Application (2016-2025) (K MT)
Table Europe Thalidomide Sales Market Share by Application (2016-2025)
Figure 2017 Europe Thalidomide Market Share by Application
Table Europe Thalidomide Sales by Company (2016-2018) (K MT)
Table Europe Thalidomide Sales Market Share by Company (2016-2018)
Figure Europe Thalidomide Sales Market Share by Company in 2017
Figure Asia Pacific Thalidomide Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Thalidomide Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Thalidomide Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Thalidomide Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Thalidomide Sales Market Share by Countries
Table Asia Pacific Thalidomide Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Thalidomide Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Thalidomide Revenue Market Share by Countries
Figure China Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure China Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Japan Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Korea Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure India Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure India Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Australia Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Thalidomide Sales by Type (2016-2025) (K MT)
Table Asia Pacific Thalidomide Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Thalidomide Market Share by Type
Table Asia Pacific Thalidomide Sales by Application (2016-2025) (K MT)
Table Asia Pacific Thalidomide Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Thalidomide Market Share by Application
Table Asia Pacific Thalidomide Sales by Company (2016-2018) (K MT)
Table Asia Pacific Thalidomide Sales Market Share by Company (2016-2018)
Figure Asia Pacific Thalidomide Sales Market Share by Company in 2017
Figure Central & South America Thalidomide Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Thalidomide Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Thalidomide Sales by Countries (2016-2025) (K MT)
Table Central & South America Thalidomide Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Thalidomide Sales Market Share by Countries
Table Central & South America Thalidomide Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Thalidomide Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Thalidomide Revenue Market Share by Countries
Figure Brazil Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Thalidomide Sales by Type (2016-2025) (K MT)
Table Central & South America Thalidomide Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Thalidomide Market Share by Type
Table Central & South America Thalidomide Sales by Application (2016-2025) (K MT)
Table Central & South America Thalidomide Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Thalidomide Market Share by Application
Table Central & South America Thalidomide Sales by Company (2016-2018) (K MT)
Table Central & South America Thalidomide Sales Market Share by Company (2016-2018)
Figure Central & South America Thalidomide Sales Market Share by Company in 2017
Figure Middle East and Africa Thalidomide Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Thalidomide Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Thalidomide Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Thalidomide Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Thalidomide Sales Market Share by Countries
Table Middle East and Africa Thalidomide Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Thalidomide Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Thalidomide Revenue Market Share by Countries
Figure GCC Countries Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Thalidomide Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Thalidomide Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Thalidomide Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Thalidomide Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Thalidomide Market Share by Type
Table Middle East and Africa Thalidomide Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Thalidomide Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Thalidomide Market Share by Application
Table Middle East and Africa Thalidomide Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Thalidomide Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Thalidomide Sales Market Share by Company in 2017
Table Celgene Company Details
Table Celgene Thalidomide Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Celgene Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Thalidomide Value Chain
Table Typical Suppliers of Key Thalidomide Raw Material
Table Thalidomide Customers List
Table Thalidomide Sales Channels
Table Thalidomide Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources